N/A
Completed N=30
Pilot Trial of Phototherapy for Acute Depression in Hospitalized Cystic Fibrosis Patients
Source: ClinicalTrials.gov NCT01822197 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Sep 2016
Primary outcomePrimary: Length of Hospitalization — 11 days
Summary
The purpose of this study is to determine whether bright light phototherapy can improve depressive symptoms in hospitalized patients with cystic fibrosis (CF) with subsequent effects on quality of life and illness recovery. It is hypothesized that phototherapy will improve depressive symptoms and decrease length of stay in depressed patients with CF who are hospitalized.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Length of Hospitalization |
11 | — |
| SECONDARY Depressive Symptom Scores Post-Treatment (Day 7) and at Admission (Day 0) |
4.5; 8.7 | — |
| SECONDARY Quality of Life Scoring Post-Treatment (Day 7) and at Admission (Day 0 |
35.5; 59.7 | — |
Eligibility Criteria
Inclusion Criteria
- Patients with CF greater than 12 years of age
- Pulmonary exacerbation
Exclusion Criteria
- planned admission less than 24 hours
- suicidal ideation
- Bipolar depression
- known retinal disorder/photosensitivity
- light induced epilepsy or migraines
- age less than 12 years of age
Data sourced from ClinicalTrials.gov (NCT01822197). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.